Theratechnologies' Trogarzo® (Ibalizumab-uiyk) Shortens Time to HIV Undetectability and Extends ... | National
First-of-its-Kind Study in HIV Compares IbalizumabClinical Trial Experience to Matched Real-World Non-Ibalizumab OPERA®CohortData Presented at ACTHIV™Conference Highlight Improved Clinical Outcomes of Ibalizumab for Heavily Treatment-ExperiencedPeople with HIV
Source: somerset-kentucky.com